Barrow is participating in a multi-site clinical trial for a drug targeting the huntingtin protein. If you’ve been diagnosed with #Huntingtonsdisease, or you carry the abnormal huntingtin gene &amp; have early signs of HD, you may be eligible to participate:
#Huntingtonsdisease